Virginia National Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Virginia National Bank's BMY Position: Q3 2022 in Review
Virginia National Bank sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 4,458 shares — an estimated $343K sold.
Virginia National Bank first reported a position in BMY in Q1 2022 and held it in 2 quarters. The position peaked at $365K in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Virginia National Bank reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Virginia National Bank sold 4,458 Bristol-Myers Squibb shares in Q3 2022, an estimated $343K.
- Virginia National Bank first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 2 quarters.
- Virginia National Bank's Bristol-Myers Squibb position peaked at $365K in Q1 2022.
- 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Virginia National Bank's 13F filing for Q3 2022, filed 4 Nov 2022.